Kelly Jason R 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:03 pm Sale | 2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Kelly Jason R | 2,143,808 5.000% | -281,628 (-11.61%) | Filing |
| 2023-01-24 8:19 pm Sale | 2023-01-24 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Kelly Jason R | 2,425,436 6.200% | -271,324 (-10.06%) | Filing |
| 2022-10-04 9:51 pm Purchase | 2022-10-01 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Kelly Jason R | 2,696,759 8.500% | 632,232 (+30.62%) | Filing |
| 2021-09-27 5:23 pm Purchase | 2021-09-16 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Kelly Jason R | 2,064,528 5.800% | 2,064,528 (New Position) | Filing |